Table 1.
Antibacterial activity of P-PRP against oral microorganisms
|
N° of patient |
MIC (n° platelets/μl) |
||||
|---|---|---|---|---|---|
| E. faecalis VRE | E.faecalis VSE | C. albicans | S. agalactiae | S. oralis | |
| 1 |
34.475 ± 13.488 |
29.550 ± 11.013 |
88.650 ± 22.025 |
34.457 ± 13.504 |
8.618 ± 3.372 |
| 2 |
32.500 ± 19.902 |
35.750 ± 17.801 |
117.000 ± 29.069 |
39.000 ± 14.534 |
3.250 ± 1.112 |
| 3 |
5.738 ± 2.138 |
4.303 ± 1.069 |
61.200 ± 20.950 |
26.775 ± 10.475 |
3.346 ± 1.310 |
| 4 |
12.488 ± 3.103 |
16.650 ± 6.205 |
49.950 ± 12.410 |
8.305 ± 3.114 |
7.650 ± 2.619 |
| 5 |
7.613 ± 5.004 |
6.831 ± 5.263 |
112.500 ± 27.951 |
10.937 ± 4.279 |
2.734 ± 1.070 |
| 6 |
13.956 ± 6.949 |
13.956 ± 6.949 |
81.200 ± 27.797 |
8.881 ± 3.475 |
7.612 ± 2.837 |
| 7 |
6.581 ± 1.635 |
5.850 ± 2.006 |
210.600 ± 52.324 |
17.550 ± 6.540 |
26.325 ± 6.540 |
| 8 |
5.375 ± 3.292 |
5.913 ± 2.944 |
68.800 ± 23.552 |
34.400 ± 11.776 |
34.400 ± 11.776 |
| 9 |
28.425 ± 10.593 |
21.319 ± 5.297 |
75.800 ± 25.948 |
8.290 ± 3.243 |
8.290 ± 3.244 |
| 10 |
5.611 ± 2.195 |
4.809 ± 1.792 |
38.475 ± 14.339 |
12.825 ± 4.391 |
14.428 ± 3.585 |
| 11 |
24.200 ± 8.284 |
21.175 ± 8.284 |
108.900 ± 27.056 |
36.300 ± 13.528 |
33.275 ± 16.569 |
| 12 |
14.000 ± 4.793 |
13.125 ± 6.187 |
31.500 ± 7.826 |
15.750 ± 3.913 |
17.500 ± 10.717 |
| 13 |
9.075 ± 4.519 |
10.725 ± 5.534 |
39.600 ± 14.758 |
33.000 ± 20.208 |
29.700 ± 7.279 |
| 14 |
19.906 ± 11.682 |
15.641 ± 11.682 |
68.250 ± 25.435 |
15.640 ± 7.788 |
4.976 ± 1.947 |
| 15 |
24.850 ± 9.722 |
21.300 ± 7.938 |
63.900 ± 15.876 |
49.700 ± 19.444 |
6.212 ± 2.431 |
| 16 |
14.850 ± 10.757 |
11.550 ± 4.519 |
46.200 ± 18.075 |
9.900 ± 3.690 |
18.150 ± 9.037 |
| 17 |
11.375 ± 5.870 |
8.750 ± 5.358 |
86.800 ± 53.677 |
12.250 ± 4.793 |
6.125 ± 2.396 |
| RANGE | 5.375 – 34.475 | 4.303 – 35.750 | 31.500 – 210.600 | 8.290 – 49.700 | 2.734 – 34.400 |
Data are expressed as mean ± standard deviation.